Community Home

Log in or Join to View Discussions

Latest Discussion Posts

  • Hello DIA members! As our community grows and evolves, DIA is continually evaluating how to best serve you, both online and off. To that end, we have begun instituting small improvements to the DIA Communities site that we hope will make it easier for ...

  • Leaders from the DIA Study Endpoint, Clinical Research, and Statistics & Data Science Communities are organizing a Working Group with a goal of tackling the important topic clinically meaningful change – moving the discussion beyond MCID/MID and homogenous ...

  • From your Global Forum Ethnic Differences, Regulatory Policies, and COVID-19 Improving Access to CAR T Therapy: It's Not Just Payment Patient Engagement in COVID Times: Looking Behind the Numbers Global Electronic Labeling Initiatives: ...

  • Title: THE POWER OF AI IN BIOLOGICS DRUG DESIGN, PRE-CLINICAL AND CLINICAL DEVELOPMENT Date: 21 July 2020, 10:00am - 11:30am EST (14:00 - 15:30 GMT) Registration Link:   https://diaglobal.zoom.us/webinar/register/WN_VUvDHq7fRzO_057PMaZRr4 Brought ...

    1 person likes this.
  • DATE & TIME USA: 15 July 2020, 8 am to 9 am, US EST DATE & TIME INDIA: 15 July 2020, 5.30 pm to 6.30 pm IST Do join us for the kick off meeting of the DIA India MW community. We will discuss the goals and vision for the same, followed by a presentation ...

  • From your Global Forum FDA Guidance on Conduct of Clinical Trials During COVID-19 Remote Clinical Trials in China During the COVID-19 Pandemic Repurposing Challenges: Conceptualization of a Research Agenda Improving Access: Singapore's ...

  • From your Global Forum : Data Handling and Reporting for Ongoing Clinical Trials During COVID-19 Repurposing Challenges: Conceptualization of a Research Agenda Assessing the Scope of Patient Engagement in Canada Case Study: Research ...

  • From your Global Forum : COVID-19 Spurring Research Yet Shutting Down Clinical Trials in Australia Remote Clinical Trials in China During the COVID-19 Pandemic Data Handling and Reporting for Ongoing Clinical Trials During COVID-19 ...

  • I have a question regarding DIA TMF Reference Model folders 06.02.03 and 06.02.04. For Investigational Product (IP) that is sprayed using a drug delivery dispenser, there is: Certificate of Analysis (COA) for the IP Certificate of Conformance (CoC) ...

  • ​ Join us for the Advanced Therapies Content Hub – 10.15 to 10.45 am Monday 15 June 2020 Richard and I will be available in the live portion after the pre-recorded presentation has been conducted. We are providing a high-level overview of advanced ...

Upcoming Events


Shared Files & Links